Allen & Overy has advised Exscientia on the matter. Sanofi and Exscientia announced a ground breaking research collaboration and licence agreement to develop up to 15 […]
Exscientia’s USD5.2 Billion Strategic Research Collaboration with Sanofi
@properties’ Acquisition of Christie’s International Real Estate
Allen & Overy has advised Christie’s on the deal. Christie’s, the world-leading art and luxury business, sold its Christie’s International Real Estate business to real estate […]
Exscientia’s Oncology Joint Venture With GT Apeiron Therapeutics
Allen & Overy has advised Exscientia on the matter. The collaboration will leverage Exscientia’s AI-driven drug discovery platform to accelerate the discovery of multiple small molecule […]
Venture Life Group plc’s Acquisition Of BBI Healthcare
Allen & Overy advised Exponent Private Equity on the deal. Exponent Private Equity agreed to sell BBI Healthcare (BBIH) to Venture Life Group plc (Venture Life). […]
Exscientia’s USD 1.2 Billion Collaboration With Bristol Myers Squibb
Allen & Overy has advised Exscientia on the deal. The collaboration will use AI to accelerate the discovery of small molecule therapeutic drug candidates in multiple […]
Virgin Active’s Part 26A Restructuring Plan
Slaughter and May, Travers Smith LLP and Allen & Overy were involved in the matter. Virgin Active is implementing a holistic restructuring of the financial and […]